title: CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
abstract: The chemokine CXCL12 (SDF-1) and its receptor, CXCR4, have been implicated in organ-specific metastases of several malignancies. Head and neck squamous cell carcinoma (HNSCC) predominantly metastasizes to lymph nodes, and recent evidence has shown that CXCL12 stimulates HNSCC migration. We explored the potential role of CXCR4 in mediating other metastatic processes in HNSCC cells. CXCR4 mRNA and cell-surface expression was assessed in HNSCC cell lines. CXCR4 mRNA expression was detected in five HNSCC cell lines. Cell-surface CXCR4 was also detected in each of the HNSCC cell lines and in resected HNSCC tissues. CXCL12 induced rapid intracellular calcium mobilization in a metastatic HNSCC cell line (HN), as well as rapid phosphorylation of ERK-1/2. HNSCC cell adhesion to fibronectin and collagen was increased by CXCL12 treatment, while the addition of an inhibitor of ERK-1/2 signaling, PD98059, reduced the effects of CXCL12. CXCL12 also increased the active matrix metalloproteinase (MMP)-9 secreted. Thus, HNSCC cells express functional CXCR4 receptors that induce rapid intracellular signaling upon binding to CXCL12. Such binding leads to increased HNSCC cell adhesion and MMP secretion, suggesting that CXCR4 may be a novel regulator of HNSCC metastatic processes.
authors.affiliation: Department of Research, Veterans Affairs Medical Center, Northport, NY 11768, USA.
authors.forename: Ghassan J
authors.initials: GJ
authors.lastname: Samara
authors.forename: Diana M
authors.initials: DM
authors.lastname: Lawrence
authors.forename: Christian J
authors.initials: CJ
authors.lastname: Chiarelli
authors.forename: Michael D
authors.initials: MD
authors.lastname: Valentino
authors.forename: Sergey
authors.initials: S
authors.lastname: Lyubsky
authors.forename: Stanley
authors.initials: S
authors.lastname: Zucker
authors.forename: Gayle G
authors.initials: GG
authors.lastname: Vaday
mesh_terms: D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D002448:Cell Adhesion; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology*; D005434:Flow Cytometry; D020869:Gene Expression Profiling; D006258:Head and Neck Neoplasms / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism* / Q000502:physiology*; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D019718:Receptors, CXCR4 / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D019743:Chemokines, CXC; D019718:Receptors, CXCR4; D020780:Matrix Metalloproteinase 9